At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

15 April 2021
Lonza and Immunitas Therapeutics Announce Manufacturing Agreement to Rapidly...
Lonza will provide a customized version of the Ibex® Design program to rapidly advance Immunitas' lead program, IMT-009, from Development Candidate...
16 February 2021
Lonza Expands Solid Form Services for Small Molecule Drugs
Solid Form Services encompass all aspects of solid form screening and characterization of small molecule APIsOffering designed to complement Lonza...
25 March 2021
Lonza Publishes Invitation to the 2021 Annual General Meeting and 2020 Annual...
Annual General Meeting to take place on 6 May 2021 at the company’s headquarters in Basel, SwitzerlandAlbert M. Baehny proposed for re-election as...